163 related articles for article (PubMed ID: 24112766)
1. Neoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP).
Cho SW; Tzeng CW; Johnston WC; Cassera MA; Newell PH; Hammill CW; Wolf RF; Aloia TA; Hansen PD
HPB (Oxford); 2014 Apr; 16(4):350-6. PubMed ID: 24112766
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic adenocarcinoma: effects of neoadjuvant therapy on post-pancreatectomy outcomes - an American College of Surgeons National Surgical Quality Improvement Program targeted variable review.
Czosnyka NM; Borgert AJ; Smith TJ
HPB (Oxford); 2017 Oct; 19(10):927-932. PubMed ID: 28747265
[TBL] [Abstract][Full Text] [Related]
3. Does pre-operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post-operative morbidity? A case-matched analysis.
Araujo RL; Gaujoux S; Huguet F; Gonen M; D'Angelica MI; DeMatteo RP; Fong Y; Kingham TP; Jarnagin WR; Goodman KA; Allen PJ
HPB (Oxford); 2013 Aug; 15(8):574-80. PubMed ID: 23458208
[TBL] [Abstract][Full Text] [Related]
4. Utilization of chemoradiation therapy provides strongest protective effect for avoidance of postoperative pancreatic fistula following pancreaticoduodenectomy: A NSQIP analysis.
Mangieri CW; Strode MA; Moaven O; Clark CJ; Shen P
J Surg Oncol; 2020 Dec; 122(8):1604-1611. PubMed ID: 32935353
[TBL] [Abstract][Full Text] [Related]
5. Obesity and surgical complications of pancreaticoduodenectomy: An observation study utilizing ACS NSQIP.
Chang EH; Sugiyama G; Smith MC; Nealon WH; Gross DJ; Apterbach G; Coppa GF; Alfonso AE; Chung PJ
Am J Surg; 2020 Jul; 220(1):135-139. PubMed ID: 31761298
[TBL] [Abstract][Full Text] [Related]
6. Impact of neoadjuvant therapy on postoperative outcomes after pancreaticoduodenectomy.
Cools KS; Sanoff HK; Kim HJ; Yeh JJ; Stitzenberg KB
J Surg Oncol; 2018 Sep; 118(3):455-462. PubMed ID: 30114330
[TBL] [Abstract][Full Text] [Related]
7. The effects of neoadjuvant chemoradiation on pancreaticoduodenectomy—the American College of Surgeon's National Surgical Quality Improvement Program analysis.
Teng A; Lee DY; Yang CK; Rose KM; Attiyeh F
J Surg Res; 2015 Jun; 196(1):67-73. PubMed ID: 25791826
[TBL] [Abstract][Full Text] [Related]
8. Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality?
Mungo B; Molena D; Stem M; Yang SC; Battafarano RJ; Brock MV; Lidor AO
Dis Esophagus; 2015 Oct; 28(7):644-51. PubMed ID: 25059343
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant Radiation Is Associated with Fistula Formation Following Pancreaticoduodenectomy.
Zettervall SL; Ju T; Holzmacher JL; Rivas L; Lin PP; Vaziri K
J Gastrointest Surg; 2018 Jun; 22(6):1026-1033. PubMed ID: 29500685
[TBL] [Abstract][Full Text] [Related]
10. Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy.
Greenblatt DY; Kelly KJ; Rajamanickam V; Wan Y; Hanson T; Rettammel R; Winslow ER; Cho CS; Weber SM
Ann Surg Oncol; 2011 Aug; 18(8):2126-35. PubMed ID: 21336514
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Chemoradiation Therapy Is Associated with Adverse Outcomes in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Cancer.
Aziz H; Zeeshan M; Jie T; Maegawa FB
Am Surg; 2019 Nov; 85(11):1276-1280. PubMed ID: 31775971
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant therapy affects margins and margins affect all: perioperative and survival outcomes in resected pancreatic adenocarcinoma.
de Geus SWL; Kasumova GG; Sachs TE; Ng SC; Kent TS; Moser AJ; Vahrmeijer AL; Callery MP; Tseng JF
HPB (Oxford); 2018 Jun; 20(6):573-581. PubMed ID: 29426635
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors of Reoperation After Pancreatic Resection.
Lyu HG; Sharma G; Brovman E; Ejiofor J; Repaka A; Urman RD; Gold JS; Whang EE
Dig Dis Sci; 2017 Jun; 62(6):1666-1675. PubMed ID: 28341868
[TBL] [Abstract][Full Text] [Related]
14. Trends in utilization of neoadjuvant therapy and short-term outcomes in resected pancreatic cancer.
Mirkin KA; Hollenbeak CS; Gusani NJ; Wong J
Am J Surg; 2017 Jul; 214(1):80-88. PubMed ID: 27816199
[TBL] [Abstract][Full Text] [Related]
15. Length of hospital stay after craniotomy for tumor: a National Surgical Quality Improvement Program analysis.
Dasenbrock HH; Liu KX; Devine CA; Chavakula V; Smith TR; Gormley WB; Dunn IF
Neurosurg Focus; 2015 Dec; 39(6):E12. PubMed ID: 26621410
[TBL] [Abstract][Full Text] [Related]
16. Rates of Serious Complications Estimated by the ACS-NSQIP Surgical Risk Calculator in Predicting Oncologic Outcomes of Patients Treated with Pancreaticoduodenectomy for Pancreatic Head Cancer.
Choi M; Kang CM; Chong JU; Hwang HK; Yoon DS; Lee WJ
J Gastrointest Surg; 2019 Jun; 23(6):1180-1187. PubMed ID: 30465189
[TBL] [Abstract][Full Text] [Related]
17. Age 80 years and over is not associated with increased morbidity and mortality following pancreaticoduodenectomy.
Kim SY; Fink MA; Perini M; Houli N; Weinberg L; Muralidharan V; Starkey G; Jones RM; Christophi C; Nikfarjam M
ANZ J Surg; 2018 May; 88(5):E445-E450. PubMed ID: 28593708
[TBL] [Abstract][Full Text] [Related]
18. Transatlantic registries of pancreatic surgery in the United States of America, Germany, the Netherlands, and Sweden: Comparing design, variables, patients, treatment strategies, and outcomes.
Mackay TM; Gleeson EM; Wellner UF; Williamsson C; Busch OR; Groot Koerkamp B; Keck T; van Santvoort HC; Tingstedt B; Pitt HA; Besselink MG;
Surgery; 2021 Feb; 169(2):396-402. PubMed ID: 32868111
[TBL] [Abstract][Full Text] [Related]
19. The impact of race/ethnicity on pancreaticoduodenectomy outcomes for pancreatic cancer.
Alwatari Y; Mosquera CM; Khoraki J; Rustom S; Wall N; Sevdalis AE; Stover W; Trevino JG; Kaplan B
J Surg Oncol; 2023 Jan; 127(1):99-108. PubMed ID: 36177773
[TBL] [Abstract][Full Text] [Related]
20. Nationwide trends and outcomes associated with neoadjuvant therapy in pancreatic cancer: An analysis of 18 243 patients.
Youngwirth LM; Nussbaum DP; Thomas S; Adam MA; Blazer DG; Roman SA; Sosa JA
J Surg Oncol; 2017 Aug; 116(2):127-132. PubMed ID: 28407261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
